All Type of News
Possibility of generic substitution on substitution-prohibited prescriptions with no reason
Whether it is a large, medical or small hospital, generic-substitution-prohibited prescriptions have frequently been filed.
Furthermore, generic-substitution-prohibited prescriptions having no clinical reason are tro...
Hanmi Science purchases 200k m2 land in Yantai Economic Development ZoneA Hanmi Pharm’s holding company, Hanmi Science(CEO Jong-woon Lim) announced on the 29th that it has purchased land in the economic development zone in Yantai, China to establish...
|
Pharmaceutical industry looking for chance to drop pharmaceutical distribution cost
Pharmaceutical companies have frequently looked for an opportunity to raise pharmaceutical distribution costs for distribution companies.
Although it has not been processed due to the pharmaceutical distribution indu...
Korean PDR will be released next year
The Ministry of Food and Drug Safety(MFDS) is working on publishing the ‘Korean Physician’s Desk References’ to support the domestic pharmaceutical industry as well as its pharmacopoeia.
The MFDS has established deta...
Pharmaceutical industry aiming for ‘UN Healthcare Project Service Market’
The UN’s(United Nations) healthcare project service market is getting bigger. Domestic pharmaceutical companies have actively put efforts on entering the market, and their shares in the market is enlarging. The market...
Korea United Pharma succeed in registering ‘Cilostan CR’ in foreign countries
Korea United Pharma(CEO Duk-young Kang) acquired product approval of ‘Cilostan CR,’ an incrementally modified drug, from the Philippine Food and Drug Administration(PFDA).
Cilostan CR Tab, an incrementally modified...
Teva-Handok established by world-class pharmaceutical companies suffers in KoreaA company jointly established by an Israeli multinational pharmaceutical company ‘Teva’ and a domestic pharmaceutical company ‘Handok,’ Handok-Teva’ was known to have difficult ...
|
Average KOSPI pharmaceuticals’ sales growth rate is 1.5 times higher than one of KOSDAQ
Last year(2015), 36 KOSPI listed companies’ sales were KRW 334.5 billion on average, increased by 17.7% compared to 2014, and 26 KOSDAQ listed companies’ sales were KRW 93.3 billion increased by 11.4%, showing the gro...
Is revealing rebate survey result legal or illegal?
The Korea Pharmaceutical Manufacturers Association has attracted attention as deciding to reveal the secret voting result as one of the rebate eradication measures. Even if it plans to reveal the result only internall...
FSS begins to extensively revise excess health insurance
The Financial Supervisory Service(FSS) clarified to completely eradicate the custom that causes the increase of the excess health insurance costs.
Moreover, it announced to make the excess health insurance as the nex...
